CSL112
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
CSL112 (apolipoprotein A‐I [human]) is a novel intravenous formulation of plasma‐derived apolipoprotein A‐I (apoA‐I) that…
We have previously shown that reconstituted HDL has the ability to inactivate phospholipid hydroperoxides (PLOOH) in oxidized LDL…
Introduction: CSL112 is apolipoprotein A-I (apoA[[Unable to Display Character: ‐]]I) purified from human plasma and reconstituted…
Purpose: The ability of HDL to promote cholesterol efflux from atherosclerotic plaque is thought to underpin its potential for…